Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
PLRX compared with BOLD: revenue, margins and what each company keeps, and the suppliers and customers both name
PLRX
Pliant Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
BOLD
Boundless Bio, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
PLRX
Pliant Therapeutics, Inc.
vs
BOLD
Boundless Bio, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Earnings history
Desk
News
Calendar
Saved
Search
Earnings history
last 4 reports each · paired by recency
Method
›
PLRX
1 of 4 reports
0 of 1
at or beyond implied
Report
implied
realized
× implied
Q2 FY26
±55.4%
▲
+3.88%
×0.07
BOLD
No earnings history for BOLD.
= implied
PLRX realized, solid
BOLD realized, hatched
One scale, both sides: full bar = 56%
× = |realized| ÷ implied
Source: market data
PLRX
Pliant Therapeutics, Inc.
Change
0.85
▼
−1.58%
· post 0.85
Mkt cap
$53.2M
Revenue
$248,000
Q2 FY23
BOLD
Boundless Bio, Inc.
Change
2.45
▼
−1.21%
· post 2.45
Closed
Oct 30 '26
Mkt cap
$56.2M
Revenue
—
vs
Compare
Closed
Oct 30 '26
PLRX
Pliant Therapeutics, Inc.
vs
BOLD
Boundless Bio, Inc.
0.85
▼
−1.58%
post 0.85
Price
2.45
▼
−1.21%
post 2.45
$53.2M
Mkt cap
$56.2M
Q2 FY23
$248,000
Revenue
—
Change
Change
PLRX
0.85
▼
−1.58%
vs
BOLD
2.45
▼
−1.21%
Closed
Oct 30 '26